{"filing":{"accession_number":"0001193125-26-241846","cik":"0001661998","ticker":"QTTB","company_name":"Q32 Bio Inc.","form":"8-K","filing_date":"2026-05-27","report_date":null,"primary_document":"d228038d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312526241846/d228038d8k.htm"},"events":[{"id":8732,"run_id":7667,"accession_number":"0001193125-26-241846","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Q32 Bio entered into a securities purchase agreement to sell 6,725,000 shares of common stock and 150,000 pre-funded warrants to accredited investors for approximately $55 million in gross proceeds under a PIPE (private investment in public equity) transaction relying on Section 4(a)(2) exemption. The company plans to file a Registration Statement for resale of the securities.","company_name":"Q32 Bio Inc.","ticker":"QTTB","filing_date":"2026-05-27","form":"8-K","submitted_at":null,"items":[{"id":1905,"accession_number":"0001193125-26-241846","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Q32 Bio entered into a securities purchase agreement to sell 6,725,000 shares of common stock and 150,000 pre-funded warrants to accredited investors for approximately $55 million in gross proceeds. This is a classic PIPE (private investment in public equity) transaction involving unregistered equity issuance that will be dilutive to existing shareholders. The magnitude ($55M) and share count (6.7M+ shares plus warrant coverage) make this material to investors assessing ownership dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:14:19.238444+00:00","company_name":"","ticker":null,"filing_date":""},{"id":1906,"accession_number":"0001193125-26-241846","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities (Shares, Pre-Funded Warrants, and Warrant Shares) relying on Section 4(a)(2) exemption. This is a classic private placement or PIPE transaction that dilutes existing shareholders and is material to investor assessment of capital structure and ownership.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:14:19.238444+00:00","company_name":"","ticker":null,"filing_date":""},{"id":1907,"accession_number":"0001193125-26-241846","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The filing discloses an \"Offering\" involving \"PIPE Investors,\" \"Shares,\" and \"Warrant Shares\" with anticipated proceeds and plans to file a Registration Statement for resale. This language is consistent with a private placement or PIPE (Private Investment in Public Equity) transaction, which is a dilutive equity issuance. The forward-looking statements reference closing conditions and use of proceeds, typical of capital-raising activity that would materially affect shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:14:19.238444+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1905,"accession_number":"0001193125-26-241846","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Q32 Bio entered into a securities purchase agreement to sell 6,725,000 shares of common stock and 150,000 pre-funded warrants to accredited investors for approximately $55 million in gross proceeds. This is a classic PIPE (private investment in public equity) transaction involving unregistered equity issuance that will be dilutive to existing shareholders. The magnitude ($55M) and share count (6.7M+ shares plus warrant coverage) make this material to investors assessing ownership dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:14:19.238444+00:00","company_name":"Q32 Bio Inc.","ticker":"QTTB","filing_date":"2026-05-27"},{"id":1906,"accession_number":"0001193125-26-241846","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities (Shares, Pre-Funded Warrants, and Warrant Shares) relying on Section 4(a)(2) exemption. This is a classic private placement or PIPE transaction that dilutes existing shareholders and is material to investor assessment of capital structure and ownership.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:14:19.238444+00:00","company_name":"Q32 Bio Inc.","ticker":"QTTB","filing_date":"2026-05-27"},{"id":1907,"accession_number":"0001193125-26-241846","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The filing discloses an \"Offering\" involving \"PIPE Investors,\" \"Shares,\" and \"Warrant Shares\" with anticipated proceeds and plans to file a Registration Statement for resale. This language is consistent with a private placement or PIPE (Private Investment in Public Equity) transaction, which is a dilutive equity issuance. The forward-looking statements reference closing conditions and use of proceeds, typical of capital-raising activity that would materially affect shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:14:19.238444+00:00","company_name":"Q32 Bio Inc.","ticker":"QTTB","filing_date":"2026-05-27"}]}